Alto Neuroscience, Inc. - ANRO
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Feb 18, 2026 | SCHEDULE 13G/A | Armistice Capital, LLC | 4.94% | 1,536,000 | View |
| Feb 18, 2026 | SCHEDULE 13G/A | Steven Boyd | 4.94% | 1,536,000 | View |
| Feb 17, 2026 | SCHEDULE 13G | Vestal Point Capital, LP | 8.0% | 2,485,000 | View |
| Feb 17, 2026 | SCHEDULE 13G | Ryan Wilder | 8.0% | 2,485,000 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Point72 Asset Management, L.P. | 6.8% | 2,156,497 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Point72 Capital Advisors, Inc. | 6.8% | 2,156,497 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Point72 Biotech Private Investments, LLC | 2.1% | 667,778 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Differentiated Ventures Investments, LLC | 2.1% | 667,778 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | 72 Investment Holdings, LLC | 2.1% | 667,778 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Steven A. Cohen | 8.9% | 2,824,275 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Commodore Capital LP | 9.9% | 3,245,628 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Commodore Capital Master LP | 9.9% | 3,245,628 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Robert Egen Atkinson | 9.9% | 3,245,628 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Michael Kramarz | 9.9% | 3,245,628 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Armistice Capital, LLC | 6.0% | 1,624,000 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Steven Boyd | 6.0% | 1,624,000 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | K2 HealthVentures Equity Trust LLC | 2.4% | 788,995 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Parag Shah | 2.4% | 788,995 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Anup Arora | 2.4% | 788,995 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Perceptive Advisors LLC | 9.99% | 3,249,934 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Joseph Edelman | 9.99% | 3,249,934 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Perceptive Life Sciences Master Fund, Ltd. | 9.99% | 3,249,934 | View |
| Oct 27, 2025 | SCHEDULE 13G | Commodore Capital LP | 9.8% | 3,190,267 | View |
| Oct 27, 2025 | SCHEDULE 13G | Commodore Capital Master LP | 9.8% | 3,190,267 | View |
| Oct 27, 2025 | SCHEDULE 13G | Robert Egen Atkinson | 9.8% | 3,190,267 | View |
| Oct 27, 2025 | SCHEDULE 13G | Michael Kramarz | 9.8% | 3,190,267 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.